Anne M. Sullivan has been with Sepracor since 1998 and is currently Senior Director of Business Development. In this role, she is responsible for out-licensing and establishing strategic relationships such as co-promotion deals on Sepracor's drug candidates. She also manages the in-licensing of new products and enabling technologies. Ms. Sullivan has been instrumental in Sepracor’s transition to a fully integrated pharmaceutical company, with involvement in both strategic marketing and product development activities.

Prior to joining Sepracor, Ms. Sullivan held management positions in marketing, market research, and sales at Abbott Laboratories. Ms. Sullivan is a certified public accountant and previously held positions in audit and international finance at KPMG Peat Marwick and Wang Laboratories.

Anne earned her A.B. in Economics and Accounting from the College of the Holy Cross, located in Worcester, Massachusetts in 1988, and her MBA from the Amos Tuck School of Business Administration at Dartmouth College, in 1995.